LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647
C. Qian, C.-H. Liao, B.-F. Tan, Y.-F. Chen, B.-W. Dang, J.-L. Chen, C.-B. Liu Department of Urological Surgery, The First People’s Hospital of Yulin, Yulin, China
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647, by C. Qian, C.-H. Liao, B.-F. Tan, Y.-F. Chen, B.-W. Dang, J.-L. Chen, C.-B. Liu, published in Eur Rev Med Pharmacol Sci 2020; 24 (6): 2938-2944–DOI: 10.26355/eurrev_202003_20658–PMID: 32271411” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/20658
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
C. Qian, C.-H. Liao, B.-F. Tan, Y.-F. Chen, B.-W. Dang, J.-L. Chen, C.-B. Liu
LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 17
Pages: 8628-8628
DOI: 10.26355/eurrev_202009_22771